FINWIRES · TerminalLIVE
FINWIRES

Research Alert: CFRA Retains Buy Opinion On Shares Of Johnson & Johnson

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

We keep our target of $278, 22.1x our 2027 EPS view, above JNJ's 10-year historical forward P/E average, justified by its improving growth outlook. We lift our 2026 EPS view to $11.66 from $11.63, mainly to reflect the Q1 beat. We keep our 2027 EPS at $12.58. JNJ delivered solid Q1 2026 results that were above expectations, with top-line sales growth of 9.9% Y/Y to $24.1B, demonstrating continued momentum across both the core Innovative Medicine (+11.2% Y/Y) and MedTech (+7.7% Y/Y) segments. The company reaffirmed its trajectory toward $101B in annual revenue for 2026 (CFRA: $101.3B) and expressed confidence in achieving double-digit growth by decade's end. We view this target as achievable driven by new product launches (Darzalex injectable, Icotyde, which is expected to be one of JNJ's largest products), an innovative pipeline, and key strategic initiatives (mid-2027 Orthopedics separation, which we think will unlock considerable value for JNJ and manufacturing expansions in North Carolina and Pennsylvania).

Related Articles

Treasury

Scotiabank Previews This Week's Retail Sales Data in Canada

Canadian retail sales for the month of February and the preliminary estimate for March will be released on Friday, said Scotiabank.Statistics Canada had previously indicated that February's nominal sales were tracking a gain of almost 1% month-over-month seasonally adjusted. That may be revised, which isn't uncommon, and required details like volumes versus prices and sector breakdowns will be offered, noted the bank.March is a bit of a wildcard and only the headline preliminary estimate will be offered, stated Scotiabank.Q1 is tracking the fastest growth in retail sales volumes since H2 2024, pointed out the bank. That's based on the Q4 average, the surge in January and Scotiabank's estimate of the volume portion of the preliminary guidance for February's sales, while holding March unchanged to focus the math on what is known.Investors will learn more this week, but this measure correlates very strongly with goods spending by consumers within the gross domestic product accounts.

$$CXY
Asia

Nanya Technology Buys Factory Equipment Worth NT$365 Million

Nanya Technology (TPE:2408) acquired factory equipment worth NT$365.1 million for production purposes.The equipment was purchased from Nan Ya Photonics, a related party, between December 2025 and April 2026, according to a Wednesday Taiwan Exchange filing.The purchase will support the company's operational and manufacturing needs, itthe company said.

$TPE:2408
Asia

LG, Nvidia to Develop Domain-Specific AI Models

LG AI Research Institute and Nvidia agreed to expand their collaboration to develop new AI models, LG Corp. (KRX:003550) said in a press release on Wednesday.The two entities plan to develop domain-specific AI solutions, which would involve combining LG's AI model ExaONE with Nvidia's Nemotron AI ecosystem, the release said.Shares of LG Corp. rose nearly 1% at market close.

$KRX:003550